SeaStar Medical Holding Statistics

Total Valuation

ICU has a market cap or net worth of $13.42 million. The enterprise value is $8.48 million.

Market Cap	13.42M
Enterprise Value	8.48M

Important Dates

The last earnings date was Wednesday, May 14, 2025, after market close.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

ICU has 10.56 million shares outstanding. The number of shares has increased by 271.34% in one year.

Current Share Class	10.56M
Shares Outstanding	10.56M
Shares Change (YoY)	+271.34%
Shares Change (QoQ)	+75.16%
Owned by Insiders (%)	1.24%
Owned by Institutions (%)	2.74%
Float	9.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.51
Forward PS	15.63
PB Ratio	20.81
P/TBV Ratio	23.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	19.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.64.

Current Ratio	0.96
Quick Ratio	0.77
Debt / Equity	0.64
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-158.16

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-144.37%
Return on Invested Capital (ROIC)	-4,324.71%
Return on Capital Employed (ROCE)	-3,135.22%
Revenue Per Employee	$22,526
Profits Per Employee	-$837,105
Employee Count	19
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

In the past 12 months, ICU has paid $6,000 in taxes.

Income Tax	6,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.65% in the last 52 weeks. The beta is -0.87, so ICU's price volatility has been lower than the market average.

Beta (5Y)	-0.87
52-Week Price Change	-85.65%
50-Day Moving Average	1.30
200-Day Moving Average	2.52
Relative Strength Index (RSI)	51.67
Average Volume (20 Days)	144,423

Short Selling Information

The latest short interest is 113,798, so 1.08% of the outstanding shares have been sold short.

Short Interest	113,798
Short Previous Month	282,268
Short % of Shares Out	1.08%
Short % of Float	1.21%
Short Ratio (days to cover)	0.98

Income Statement

In the last 12 months, ICU had revenue of $428,000 and -$15.91 million in losses. Loss per share was -$3.04.

Revenue	428,000
Gross Profit	428,000
Operating Income	-17.71M
Pretax Income	-33.67M
Net Income	-15.91M
EBITDA	n/a
EBIT	-17.71M
Loss Per Share	-$3.04

Full Income Statement

Balance Sheet

The company has $5.30 million in cash and $363,000 in debt, giving a net cash position of $4.93 million or $0.47 per share.

Cash & Cash Equivalents	5.30M
Total Debt	363,000
Net Cash	4.93M
Net Cash Per Share	$0.47
Equity (Book Value)	565,000
Book Value Per Share	0.06
Working Capital	-248,000

Full Balance Sheet

Cash Flow

Operating Cash Flow	-15.17M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-4,138.79%
Pretax Margin	-3,714.72%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ICU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-271.34%
Shareholder Yield	-271.34%
Earnings Yield	-118.55%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 10, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Jun 10, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

ICU has an Altman Z-Score of -32.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-32.31
Piotroski F-Score	2